Desh Rakshak Aushdhalaya Limited

DESHRAKPharmaceuticals
32.00+0.00 (+0.00%)
As on 16 Jan 2026, 10:12 amMarket Closed

Fundamental Score

...

Desh Rakshak Aushdhalaya Limited Share Price Live NSE/BSE

No data
High
0.00
Low
0.00
Volume
0
Change
+0.00%

Profitability Metrics

Poor

Return on Equity

4.94%
Poor

Return on Capital Employed

6.81%
Excellent

Operating Profit Margin (5Y)

19.58%
Poor

Dividend Yield

0.00%

Valuation Metrics

Poor

Price to Earnings

31.94x

Market Capitalization

21.08 (Cr)

Industry P/E

31.77x

Growth Metrics

Poor

YoY Quarterly Profit Growth

-46.67%
Poor

YoY Quarterly Sales Growth

-20.17%
Poor

Sales Growth (5Y)

4.38%
Poor

EPS Growth (5Y)

9.86%
Poor

Profit Growth (5Y)

9.86%

Financial Health

Excellent

Debt to Equity

0.17x
Average

Interest Coverage

2.74x
Poor

Free Cash Flow (5Y)

-1.15 (Cr)

Ownership Structure

Good

Promoter Holding

50.07%
Poor

FII Holding

0.00%
Poor

DII Holding

0.00%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.
50.07%
Promoter Holding
21.08 (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of DESHRAK across key market metrics for learning purposes.

Positive Indicators

4 factors identified

Strong Operating Margins (19.58%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.

Conservative Debt Levels (D/E: 0.17)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.

Balanced Promoter Holding (50.07%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

10 factors identified

Below-Average Return on Equity (4.94%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (6.81%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.

Profit Decline Concern (-46.67%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.

Revenue Contraction (-20.17%)

Observation: Sales decline may indicate market challenges or competitive pressures.

Analysis: Negative revenue growth requires analysis of market conditions and competitive positioning. Monitor recovery strategies.

Limited Growth History (4.38% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities. Assess future growth catalysts.

Negative Free Cash Flow (₹-1.15 Cr over 5Y)

Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.

Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.

Very Low ROE

Observation: Poor capital utilization and shareholder returns.

Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.

High P/E Ratio

Observation: Stock may be overvalued relative to earnings.

Analysis: P/E above 30 requires strong growth execution to justify current valuations.

Small Market Cap

Observation: Higher investment risk due to limited size.

Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.

Financial Statements

Comprehensive financial data for Desh Rakshak Aushdhalaya Limited

About DESHRAK

Business Overview

Desh Rakshak Aushdhalaya Limited engages in the manufacture and sale of ayurvedic and herbal products in India. It manufactures and processes ayurvedic medicines, ayurvedic composite drug kits, dye kits, and CHW kits. The company also provides medicines in tablet, capsule, pills, powder, syrup, and liquid forms. It also exports its products. The company was founded in 1901 and is headquartered in Haridwar, India.

Company Details

Symbol:DESHRAK
Industry:Pharmaceuticals
Sector:Pharmaceuticals

Key Leadership

Mr. Tosh Kumar Jain
Chairman & MD
Ms. Monika Jain
Whole Time Director
Mr. Arihant Kumar Jain
Whole Time Director

DESHRAK Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)4.94%
Return on Capital Employed6.81%
Operating Profit Margin (5Y)19.58%
Debt to Equity Ratio0.17
Interest Coverage Ratio2.74

Growth & Valuation

Sales Growth (5Y)4.38%
Profit Growth (5Y)9.86%
EPS Growth (5Y)9.86%
YoY Quarterly Profit Growth-46.67%
YoY Quarterly Sales Growth-20.17%

Frequently Asked Questions

What is the current price of Desh Rakshak Aushdhalaya Limited (DESHRAK)?

As of 16 Jan 2026, 10:12 am IST, Desh Rakshak Aushdhalaya Limited (DESHRAK) is currently trading at ₹32.00. The stock has a market capitalization of ₹21.08 (Cr).

Is DESHRAK share price Overvalued or Undervalued?

DESHRAK is currently trading at a P/E ratio of 31.94x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.

What factors affect the Desh Rakshak Aushdhalaya Limited share price?

Key factors influencing DESHRAK's price include its quarterly earnings growth (Sales Growth: -20.17%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Desh Rakshak Aushdhalaya Limited a good stock for long-term investment?

Desh Rakshak Aushdhalaya Limited shows a 5-year Profit Growth of 9.86% and an ROE of 4.94%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.17 before investing.

How does Desh Rakshak Aushdhalaya Limited compare with its industry peers?

Desh Rakshak Aushdhalaya Limited competes with major peers in the Pharmaceuticals. Investors should compare DESHRAK's P/E of 31.94x and ROE of 4.94% against the industry averages to determine its competitive standing.

What is the P/E ratio of DESHRAK and what does it mean?

DESHRAK has a P/E ratio of 31.94x compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹32 for every ₹1 of annual earnings.

How is DESHRAK performing according to Bull Run's analysis?

DESHRAK has a Bull Run fundamental score of 28.2/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.

What sector and industry does DESHRAK belong to?

DESHRAK operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Desh Rakshak Aushdhalaya Limited.

What is Return on Equity (ROE) and why is it important for DESHRAK?

DESHRAK has an ROE of 4.94%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Desh Rakshak Aushdhalaya Limited generates profits from shareholders' equity.

How is DESHRAK's debt-to-equity ratio and what does it indicate?

DESHRAK has a debt-to-equity ratio of 0.17, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.

What is DESHRAK's dividend yield and is it a good dividend stock?

DESHRAK offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.

How has DESHRAK grown over the past 5 years?

DESHRAK has achieved 5-year growth rates of: Sales Growth 4.38%, Profit Growth 9.86%, and EPS Growth 9.86%.

What is the promoter holding in DESHRAK and why does it matter?

Promoters hold 50.07% of DESHRAK shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.

What is DESHRAK's market capitalization category?

DESHRAK has a market capitalization of ₹21 crores, placing it in the Small-cap category.

How volatile is DESHRAK stock?

DESHRAK has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is the 52-week high and low for DESHRAK?

DESHRAK has a 52-week high of ₹N/A and low of ₹N/A.

What is DESHRAK's operating profit margin trend?

DESHRAK has a 5-year average Operating Profit Margin (OPM) of 19.58%, indicating the company's operational efficiency.

How is DESHRAK's quarterly performance?

Recent quarterly performance shows YoY Sales Growth of -20.17% and YoY Profit Growth of -46.67%.

What is the institutional holding pattern in DESHRAK?

DESHRAK has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.